BIO-Key International Inc (BKYI)
$0.97 $0.00 (0.51%) 4:38 PM 12/13/24
NASDAQ | $USD | Security & Protection ServicesStock Data
-
Market Cap
$3.25M -
Day's Range
$0.97 - $1.00 -
Volume
151,840 -
52 Week Low / High
$0.52 - $4.12 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 0
- Strong Buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $2.00
- Target Price
Company News
-
BIO-key International Inc (BKYI) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... — Oct 9th, 2024
Revenue: $1.1 million in Q2 2024, down from $1.9 million in Q2 2023. Gross Margin: Improved to 77% in Q2 2024 from 69% in Q2 2023. Net Loss: $1.7 million, or $1 per share, in Q2 2024, improved from $2.6 million, or $4.71 per share, in Q2 2023. Operating Expenses: Reduced by $168,000 in Q2 ...
-
BIO-key International Inc (BKYI) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... — Oct 9th, 2024
Revenue: $1.1 million in Q2 2024, down from $1.9 million in Q2 2023. Gross Margin: Improved to 77% in Q2 2024 from 69% in Q2 2023. Net Loss: $1.7 million, or $1 per share, in Q2 2024, improved from $2.6 million, or $4.71 per share, in Q2 2023. Operating Expenses: Reduced by $168,000 in Q2 ...
-
BIO-key International Inc (BKYI) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... — Oct 9th, 2024
Revenue: $1.1 million in Q2 2024, down from $1.9 million in Q2 2023. Gross Margin: Improved to 77% in Q2 2024 from 69% in Q2 2023. Net Loss: $1.7 million, or $1 per share, in Q2 2024, improved from $2.6 million, or $4.71 per share, in Q2 2023. Operating Expenses: Reduced by $168,000 in Q2 ...
-
BIO-key International Inc (BKYI) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... — Oct 9th, 2024
Revenue: $1.1 million in Q2 2024, down from $1.9 million in Q2 2023. Gross Margin: Improved to 77% in Q2 2024 from 69% in Q2 2023. Net Loss: $1.7 million, or $1 per share, in Q2 2024, improved from $2.6 million, or $4.71 per share, in Q2 2023. Operating Expenses: Reduced by $168,000 in Q2 ...
-
BIO-key International Inc (BKYI) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... — Oct 9th, 2024
Revenue: $1.1 million in Q2 2024, down from $1.9 million in Q2 2023. Gross Margin: Improved to 77% in Q2 2024 from 69% in Q2 2023. Net Loss: $1.7 million, or $1 per share, in Q2 2024, improved from $2.6 million, or $4.71 per share, in Q2 2023. Operating Expenses: Reduced by $168,000 in Q2 ...
-
BIO-key International Inc (BKYI) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... — Oct 9th, 2024
Revenue: $1.1 million in Q2 2024, down from $1.9 million in Q2 2023. Gross Margin: Improved to 77% in Q2 2024 from 69% in Q2 2023. Net Loss: $1.7 million, or $1 per share, in Q2 2024, improved from $2.6 million, or $4.71 per share, in Q2 2023. Operating Expenses: Reduced by $168,000 in Q2 ...
-
BIO-key International Inc (BKYI) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... — Oct 9th, 2024
Revenue: $1.1 million in Q2 2024, down from $1.9 million in Q2 2023. Gross Margin: Improved to 77% in Q2 2024 from 69% in Q2 2023. Net Loss: $1.7 million, or $1 per share, in Q2 2024, improved from $2.6 million, or $4.71 per share, in Q2 2023. Operating Expenses: Reduced by $168,000 in Q2 ...
-
BIO-key International Inc (BKYI) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... — Oct 9th, 2024
Revenue: $1.1 million in Q2 2024, down from $1.9 million in Q2 2023. Gross Margin: Improved to 77% in Q2 2024 from 69% in Q2 2023. Net Loss: $1.7 million, or $1 per share, in Q2 2024, improved from $2.6 million, or $4.71 per share, in Q2 2023. Operating Expenses: Reduced by $168,000 in Q2 ...
Portfolio
Comprised of 1 portfolios